Predictors for long‐term survival after transcatheter edge‐to‐edge mitral valve repair
Objectives To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long‐term outcome in high‐risk real‐world patients. Methods From August 2...
Saved in:
Published in | Journal of interventional cardiology Vol. 30; no. 3; pp. 226 - 233 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Hindawi Limited
01.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives
To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR).
Background
There is no data on predictors of long‐term outcome in high‐risk real‐world patients.
Methods
From August 2009 to April 2011, 126 high‐risk patients deemed inoperable were treated with TMVR in two high‐volume university centers.
Results
MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long‐term clinical follow‐up up to 5 years (95.2% follow‐up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long‐term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post‐procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long‐term mortality. Patients with primary MR and a post‐procedural MR grade ≤1 had the most favorable long‐term outcome.
Conclusions
This study determines predictors of long‐term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long‐term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR—especially in selected high‐risk patients with primary MR who are not considered as candidates for surgical MVR. |
---|---|
AbstractList | Objectives
To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR).
Background
There is no data on predictors of long‐term outcome in high‐risk real‐world patients.
Methods
From August 2009 to April 2011, 126 high‐risk patients deemed inoperable were treated with TMVR in two high‐volume university centers.
Results
MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long‐term clinical follow‐up up to 5 years (95.2% follow‐up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long‐term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post‐procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long‐term mortality. Patients with primary MR and a post‐procedural MR grade ≤1 had the most favorable long‐term outcome.
Conclusions
This study determines predictors of long‐term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long‐term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR—especially in selected high‐risk patients with primary MR who are not considered as candidates for surgical MVR. Objectives To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long‐term outcome in high‐risk real‐world patients. Methods From August 2009 to April 2011, 126 high‐risk patients deemed inoperable were treated with TMVR in two high‐volume university centers. Results MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long‐term clinical follow‐up up to 5 years (95.2% follow‐up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long‐term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post‐procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long‐term mortality. Patients with primary MR and a post‐procedural MR grade ≤1 had the most favorable long‐term outcome. Conclusions This study determines predictors of long‐term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long‐term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR—especially in selected high‐risk patients with primary MR who are not considered as candidates for surgical MVR. OBJECTIVESTo determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral regurgitation (MR).BACKGROUNDThere is no data on predictors of long-term outcome in high-risk real-world patients.METHODSFrom August 2009 to April 2011, 126 high-risk patients deemed inoperable were treated with TMVR in two high-volume university centers.RESULTSMR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long-term clinical follow-up up to 5 years (95.2% follow-up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long-term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post-procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long-term mortality. Patients with primary MR and a post-procedural MR grade ≤1 had the most favorable long-term outcome.CONCLUSIONSThis study determines predictors of long-term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long-term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR-especially in selected high-risk patients with primary MR who are not considered as candidates for surgical MVR. To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). There is no data on predictors of long-term outcome in high-risk real-world patients. From August 2009 to April 2011, 126 high-risk patients deemed inoperable were treated with TMVR in two high-volume university centers. MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long-term clinical follow-up up to 5 years (95.2% follow-up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long-term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post-procedural grade of MR (hazard ratio [HR] 1.55 per grade, P = 0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P = 0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P < 0.001) were independent predictors for long-term mortality. Patients with primary MR and a post-procedural MR grade ≤1 had the most favorable long-term outcome. This study determines predictors of long-term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long-term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR-especially in selected high-risk patients with primary MR who are not considered as candidates for surgical MVR. Objectives To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral regurgitation (MR). Background There is no data on predictors of long-term outcome in high-risk real-world patients. Methods From August 2009 to April 2011, 126 high-risk patients deemed inoperable were treated with TMVR in two high-volume university centers. Results MR could be successfully reduced to grade ≤2 in 92.1% of patients (116/126 patients). Long-term clinical follow-up up to 5 years (95.2% follow-up rate) revealed a mortality rate of 35.7% (45/126 patients). Repeat mitral valve treatment (surgery or intervention) was needed in 19 patients (15.1%). Long-term clinical improvement was demonstrated with 69% of patients being in NYHA class ≤II. In a multivariable Cox regression analysis, the post-procedural grade of MR (hazard ratio [HR] 1.55 per grade, P=0.035), the left ventricular ejection fraction (HR 0.58 for difference between 75th and 25th percentile, P=0.031) and the glomerular filtration rate (HR 0.33 for 75th vs 25th percentile, P<0.001) were independent predictors for long-term mortality. Patients with primary MR and a post-procedural MR grade ≤1 had the most favorable long-term outcome. Conclusions This study determines predictors of long-term clinical outcome after TMVR and demonstrates that the grade of residual MR determines long-term survival. Our data suggest that it might be of benefit reducing residual MR to the lowest possible MR grade using TMVR--especially in selected high-risk patients with primary MR who are not considered as candidates for surgical MVR. |
Author | Hagl, Christian Khandoga, Alexander Lesevic, Hasema Orban, Martin Ott, Ilka Deseive, Simon Hutterer, Lisa Schunkert, Heribert Mehilli, Julinda Kastrati, Adnan Pache, Jürgen Braun, Daniel Sonne, Carolin Orban, Mathias Bauer, Axel Grebmer, Christian Boekstegers, Peter Hausleiter, Jörg Nabauer, Michael Massberg, Steffen |
Author_xml | – sequence: 1 givenname: Mathias orcidid: 0000-0001-7846-8808 surname: Orban fullname: Orban, Mathias organization: Technische Universität München – sequence: 2 givenname: Martin orcidid: 0000-0001-9830-1941 surname: Orban fullname: Orban, Martin email: martinorban@gmail.com organization: Technische Universität München – sequence: 3 givenname: Hasema surname: Lesevic fullname: Lesevic, Hasema organization: Technische Universität München – sequence: 4 givenname: Daniel surname: Braun fullname: Braun, Daniel organization: Technische Universität München – sequence: 5 givenname: Simon surname: Deseive fullname: Deseive, Simon organization: Technische Universität München – sequence: 6 givenname: Carolin surname: Sonne fullname: Sonne, Carolin organization: Technische Universität München – sequence: 7 givenname: Lisa surname: Hutterer fullname: Hutterer, Lisa organization: Ludwig‐Maximilians‐Universität München – sequence: 8 givenname: Christian surname: Grebmer fullname: Grebmer, Christian organization: Technische Universität München – sequence: 9 givenname: Alexander surname: Khandoga fullname: Khandoga, Alexander organization: Technische Universität München – sequence: 10 givenname: Jürgen surname: Pache fullname: Pache, Jürgen organization: Starnberg‐Berg – sequence: 11 givenname: Julinda surname: Mehilli fullname: Mehilli, Julinda organization: partner site Munich Heart Alliance – sequence: 12 givenname: Heribert surname: Schunkert fullname: Schunkert, Heribert organization: partner site Munich Heart Alliance – sequence: 13 givenname: Adnan surname: Kastrati fullname: Kastrati, Adnan organization: partner site Munich Heart Alliance – sequence: 14 givenname: Christian surname: Hagl fullname: Hagl, Christian organization: Ludwig‐Maximilians‐Universität München – sequence: 15 givenname: Axel surname: Bauer fullname: Bauer, Axel organization: Ludwig‐Maximilians‐Universität München – sequence: 16 givenname: Steffen surname: Massberg fullname: Massberg, Steffen organization: partner site Munich Heart Alliance – sequence: 17 givenname: Peter surname: Boekstegers fullname: Boekstegers, Peter organization: HELIOS Klinikum Siegburg – sequence: 18 givenname: Michael surname: Nabauer fullname: Nabauer, Michael organization: Ludwig‐Maximilians‐Universität München – sequence: 19 givenname: Ilka surname: Ott fullname: Ott, Ilka organization: Technische Universität München – sequence: 20 givenname: Jörg surname: Hausleiter fullname: Hausleiter, Jörg organization: Technische Universität München |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28370526$$D View this record in MEDLINE/PubMed |
BookMark | eNp90MtKAzEUBuAgFXvRjQ8gA25EmJrLXDJLKV4qBV3oTghp5qROmZnUZKbSnY_gM_okZmx14cIskhz4-Dn8Q9SrTQ0IHRM8Jv5cLE2hxoSyNNlDAxJHOOSEsx4aYJ4lYcRo2kdD55YYUxzH9AD1KWcpjmkyQM8PFvJCNca6QBsblKZefL5_NGCrwLV2XaxlGUjt56CxsnZKNi_QTZAvoIPGX90_qAoPysD7NQQWVrKwh2hfy9LB0e4doafrq8fJbTi7v5lOLmehYnGahHE0l1qxeaZozjiLNac0k_NESUi0xBnXUuVUyYRiCUB1pFIGmvI4zwhjVLIROtvmrqx5bcE1oiqcgrKUNZjWCcJ5RJKMYOLp6R-6NK2t_XaCZL4ezDKMvTrfKmWNcxa0WNmiknYjCBZd56LrXHx37vHJLrKdV5D_0p-SPSBb8FaUsPknStzdTyfb0C_kYZHm |
CitedBy_id | crossref_primary_10_1016_j_crvasa_2018_07_006 crossref_primary_10_1016_j_jcin_2020_02_028 crossref_primary_10_1016_j_jcin_2020_09_035 crossref_primary_10_1093_ehjci_jead210 crossref_primary_10_4244_EIJ_D_19_00718 crossref_primary_10_1016_j_jcin_2022_12_015 crossref_primary_10_3390_jcm10204748 crossref_primary_10_1016_j_ijcard_2024_132317 crossref_primary_10_1016_j_jcin_2023_02_029 crossref_primary_10_1111_eci_13473 crossref_primary_10_3390_jcm10225448 crossref_primary_10_1016_j_jcin_2020_09_050 crossref_primary_10_1016_j_jcmg_2018_02_024 crossref_primary_10_1053_j_semtcvs_2021_07_030 crossref_primary_10_1007_s12928_019_00610_z crossref_primary_10_20517_2574_1225_2020_69 crossref_primary_10_1080_17434440_2020_1714433 crossref_primary_10_1016_j_ahj_2019_06_015 crossref_primary_10_1016_j_jacc_2021_11_041 crossref_primary_10_1016_j_jcin_2019_10_023 crossref_primary_10_1016_j_jcin_2019_09_014 crossref_primary_10_1016_j_jscai_2022_100495 crossref_primary_10_1016_j_jcin_2019_04_019 crossref_primary_10_1002_ejhf_1774 crossref_primary_10_1007_s00392_021_01961_5 crossref_primary_10_1016_j_jcin_2021_06_005 crossref_primary_10_4244_AIJ_D_22_00049 crossref_primary_10_1016_j_hlc_2021_11_017 crossref_primary_10_1016_j_jcmg_2022_02_017 crossref_primary_10_4244_EIJ_D_17_01136 crossref_primary_10_1016_j_carrev_2021_05_020 crossref_primary_10_1016_j_jcin_2020_12_042 crossref_primary_10_1016_j_carrev_2021_11_012 crossref_primary_10_1016_j_jcin_2022_01_277 crossref_primary_10_37615_retic_v6n1a2 crossref_primary_10_1002_ccd_30245 crossref_primary_10_1016_j_jcin_2019_03_023 crossref_primary_10_1016_j_amjcard_2020_06_025 crossref_primary_10_3390_diagnostics13152470 crossref_primary_10_1016_j_echo_2018_01_012 crossref_primary_10_1161_CIRCULATIONAHA_120_053061 crossref_primary_10_1016_j_jcmg_2020_08_019 crossref_primary_10_3389_fcvm_2020_546279 crossref_primary_10_1007_s00392_018_1365_5 |
Cites_doi | 10.4244/EIJV8I12A211 10.1093/eurjhf/hfs214 10.1111/1755-5922.12058 10.1016/S0735-1097(85)80418-6 10.1111/joic.12193 10.1093/eurjhf/hfr029 10.4244/EIJV10I2A41 10.1002/ccd.25331 10.1016/0002-9149(85)90574-0 10.1016/S0894-7317(03)00335-3 10.1056/NEJMoa1009355 10.4244/EIJY15M09_07 10.1016/j.jacc.2015.10.018 10.1001/archinte.167.22.2490 10.1093/eurheartj/eht386 10.1093/eurheartj/ehi555 10.1161/hc37t1.094903 10.1093/eurheartj/ehv627 10.1016/j.athoracsur.2008.01.079 10.1136/openhrt-2014-000056 |
ContentType | Journal Article |
Copyright | 2017, Wiley Periodicals, Inc. 2017 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2017, Wiley Periodicals, Inc. – notice: 2017 Wiley Periodicals, Inc. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 K9. 7X8 |
DOI | 10.1111/joic.12376 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1540-8183 |
EndPage | 233 |
ExternalDocumentID | 10_1111_joic_12376 28370526 JOIC12376 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJEY AAONW AAWTL AAZKR ABCQN ABDBF ABEML ABJNI ABOCM ABPVW ABUWG ACBWZ ACCFJ ACGFS ACMXC ACPRK ACSCC ACXQS ADBBV ADEOM ADIZJ AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFKRA AFPWT AFZJQ AHEFC AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS AMBMR ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BCNDV BDRZF BENPR BHBCM BMXJE BPHCQ BPMNR BROTX BRXPI BVXVI BY8 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DC6 DCZOG DPXWK DR2 DU5 EAD EAP EAS EBD EBS EJD EMB EMK EMOBN ENC EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FYUFA FZ0 G-S G.N GODZA GROUPED_DOAJ H.X HF~ HMCUK HVGLF HYE HZI HZ~ IAO IHE IHR INH IX1 J0M K48 LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D PALCI PGMZT PIMPY PQQKQ Q.N Q11 QB0 Q~Q R.K RHX RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 ZZTAW ~IA ~WT CGR CUY CVF ECM EIF ITC NPM AAYXX CITATION 7T5 H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3576-54bafc3b9c2d3835f8229ab6cae6fa098facd2ca620aee2f4c73ef285d91332a3 |
IEDL.DBID | DR2 |
ISSN | 0896-4327 |
IngestDate | Fri Oct 25 01:30:00 EDT 2024 Thu Oct 10 17:48:45 EDT 2024 Thu Sep 26 18:49:18 EDT 2024 Sat Sep 28 08:45:48 EDT 2024 Sat Aug 24 01:11:49 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | percutaneous edge-to-edge mitral valve repair heart failure MitraClip mitral valve regurgitation functional mitral regurgitation transcatheter edge-to-edge mitral valve repair |
Language | English |
License | 2017, Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3576-54bafc3b9c2d3835f8229ab6cae6fa098facd2ca620aee2f4c73ef285d91332a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7846-8808 0000-0001-9830-1941 |
PMID | 28370526 |
PQID | 1920503900 |
PQPubID | 2045134 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1884169101 proquest_journals_1920503900 crossref_primary_10_1111_joic_12376 pubmed_primary_28370526 wiley_primary_10_1111_joic_12376_JOIC12376 |
PublicationCentury | 2000 |
PublicationDate | June 2017 2017-Jun 2017-06-00 20170601 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: June 2017 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of interventional cardiology |
PublicationTitleAlternate | J Interv Cardiol |
PublicationYear | 2017 |
Publisher | Hindawi Limited |
Publisher_xml | – name: Hindawi Limited |
References | 2014; 1 2007; 167 2013; 15 2015; 28 1985; 5 2006; 27 2015; 66 2003; 16 2014; 35 2011; 13 2008; 85 2013; 8 2014; 84 1985; 56 2016; 37 2001; 104 2011; 364 2014; 32 2014; 10 2016; 12 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_10_1 e_1_2_8_21_1 e_1_2_8_11_1 e_1_2_8_12_1 |
References_xml | – volume: 27 start-page: 65 year: 2006 end-page: 75 article-title: Predictors of mortality and morbidity in patients with chronic heart failure publication-title: Eur Heart J – volume: 104 start-page: I1 year: 2001 end-page: I7 article-title: Very long‐term survival and durability of mitral valve repair for mitral valve prolapse publication-title: Circulation – volume: 66 start-page: 2844 year: 2015 end-page: 2854 article-title: Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5‐year results of EVEREST II publication-title: J Am Coll Cardiol – volume: 85 start-page: 1537 year: 2008 end-page: 1542 article-title: Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation publication-title: Ann Thorac Surg – volume: 5 start-page: 811 year: 1985 end-page: 826 article-title: Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy publication-title: J Am Coll Cardiol – volume: 32 start-page: 66 year: 2014 end-page: 73 article-title: Percutaneous mitral repair with the MitraClip system in patients with mild‐to‐moderate and severe heart failure: a single‐centre experience publication-title: Cardiovasc Ther – volume: 13 start-page: 569 year: 2011 end-page: 576 article-title: MitraClip(R) therapy in patients with end‐stage systolic heart failure publication-title: Eur J Heart Fail – volume: 167 start-page: 2490 year: 2007 end-page: 2496 article-title: Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II Study publication-title: Arch Intern Med – volume: 1 start-page: e000056 year: 2014 article-title: Two‐year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome publication-title: Open Heart – volume: 56 start-page: 99 year: 1985 end-page: 105 article-title: Left ventricular stress‐dimension‐shortening relations before and after correction of chronic aortic and mitral regurgitation publication-title: Am J Cardiol – volume: 10 start-page: 253 year: 2014 end-page: 259 article-title: Dangerous liaison: successful percutaneous edge‐to‐edge mitral valve repair in patients with end‐stage systolic heart failure can cause left ventricular thrombus formation publication-title: EuroIntervention – volume: 35 start-page: 455 year: 2014 end-page: 469 article-title: Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta‐analysis publication-title: Eur Heart J – volume: 12 start-page: 508 year: 2016 end-page: 514 article-title: Predictors for short‐term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function publication-title: EuroIntervention – volume: 364 start-page: 1395 year: 2011 end-page: 1406 article-title: Percutaneous repair or surgery for mitral regurgitation publication-title: N Eng J Med – volume: 15 start-page: 786 year: 2013 end-page: 795 article-title: Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure publication-title: Eur J Heart Fail – volume: 8 start-page: 1379 year: 2013 end-page: 1387 article-title: Three‐dimensional transoesophageal echocardiography for the assessment of clip attachment to the leaflets in percutaneous edge‐to‐edge repair of the mitral valve publication-title: EuroIntervention – volume: 84 start-page: 137 year: 2014 end-page: 146 article-title: Percutaneous edge‐to‐edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation publication-title: Catheter Cardiovasc Interv – volume: 28 start-page: 164 year: 2015 end-page: 171 article-title: Long‐term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge‐to‐edge mitral valve repair publication-title: J Interv Cardiol – volume: 37 start-page: 703 year: 2016 end-page: 712 article-title: One‐year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry publication-title: Eur Heart J – volume: 16 start-page: 777 year: 2003 end-page: 802 article-title: Recommendations for evaluation of the severity of native valvular regurgitation with two‐dimensional and Doppler echocardiography publication-title: J Am Soc Echocardiogr – ident: e_1_2_8_4_1 doi: 10.4244/EIJV8I12A211 – ident: e_1_2_8_15_1 doi: 10.1093/eurjhf/hfs214 – ident: e_1_2_8_8_1 doi: 10.1111/1755-5922.12058 – ident: e_1_2_8_12_1 doi: 10.1016/S0735-1097(85)80418-6 – ident: e_1_2_8_17_1 doi: 10.1111/joic.12193 – ident: e_1_2_8_16_1 doi: 10.1093/eurjhf/hfr029 – ident: e_1_2_8_13_1 doi: 10.4244/EIJV10I2A41 – ident: e_1_2_8_10_1 doi: 10.1002/ccd.25331 – ident: e_1_2_8_11_1 doi: 10.1016/0002-9149(85)90574-0 – ident: e_1_2_8_5_1 doi: 10.1016/S0894-7317(03)00335-3 – ident: e_1_2_8_2_1 doi: 10.1056/NEJMoa1009355 – ident: e_1_2_8_21_1 doi: 10.4244/EIJY15M09_07 – ident: e_1_2_8_3_1 doi: 10.1016/j.jacc.2015.10.018 – ident: e_1_2_8_19_1 doi: 10.1001/archinte.167.22.2490 – ident: e_1_2_8_20_1 doi: 10.1093/eurheartj/eht386 – ident: e_1_2_8_14_1 doi: 10.1093/eurheartj/ehi555 – ident: e_1_2_8_6_1 doi: 10.1161/hc37t1.094903 – ident: e_1_2_8_18_1 doi: 10.1093/eurheartj/ehv627 – ident: e_1_2_8_9_1 doi: 10.1016/j.athoracsur.2008.01.079 – ident: e_1_2_8_7_1 doi: 10.1136/openhrt-2014-000056 |
SSID | ssj0020552 |
Score | 2.3746016 |
Snippet | Objectives
To determine predictors for long‐term outcome in high‐risk patients undergoing transcatheter edge‐to‐edge mitral valve repair (TMVR) for severe... To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe mitral... Objectives To determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe... OBJECTIVESTo determine predictors for long-term outcome in high-risk patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for severe... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 226 |
SubjectTerms | Aged Cardiac Catheterization - methods Cardiac Catheterization - statistics & numerical data Catheters Female functional mitral regurgitation Germany - epidemiology Glomerular filtration rate Heart heart failure Heart Valve Prosthesis Implantation - adverse effects Heart Valve Prosthesis Implantation - methods Heart Valve Prosthesis Implantation - mortality Humans Long Term Adverse Effects - mortality Long Term Adverse Effects - surgery Male Middle Aged MitraClip Mitral valve Mitral Valve - surgery Mitral Valve Insufficiency - diagnosis Mitral Valve Insufficiency - physiopathology Mitral Valve Insufficiency - surgery mitral valve regurgitation Mortality percutaneous edge‐to‐edge mitral valve repair Proportional Hazards Models Regurgitation Risk Adjustment - methods Risk Factors Risk groups Severity of Illness Index Surgery Survival transcatheter edge‐to‐edge mitral valve repair Treatment Outcome Ventricle Ventricular Function, Left |
Title | Predictors for long‐term survival after transcatheter edge‐to‐edge mitral valve repair |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoic.12376 https://www.ncbi.nlm.nih.gov/pubmed/28370526 https://www.proquest.com/docview/1920503900 https://search.proquest.com/docview/1884169101 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDohLKY-WpYCM4FQpq8SOvYnEBfEQRYJWVZE4tIpsx0YrIKn20QMnfgK_kV_CjJONSitVKpfIUSa24_F4Hp58BtgTWklhsjQSNvFRKnwc5aX3kSszkXml0yzEIc8v1OllenYlr-Zgf_YvTIMP0QXcSDLCek0Crs34dyGvh7afUFIHLsCJGFA-19HXDjuKxzIctxNnucI-8EGLTRrSeLpXX2qjv0zMlxZrUDknS_Bj1tkm0-SmP52Yvr3_A8fxtV_zFt60tig7aCbPMsy5agUWztvd9lX4_mVEZTqPh6Fty27r6vrp4ZEWczae4hqDs5SFQ8bZhFRegIClO4rREWGNFyqzuyEFVBjS_3JshBpwOFqDy5Pjb4enUXsaQ2QFOiWRTI32Vpjc8hLdWukJKl4bZbVTXsd55rUtudWKx9o57lM7EM7zTJY5-sFci3cwX9WVWwdmkNBJOTBWYa2JMej3JQqJvcMhsLwHuzOuFD8b0I2ic1ZwoIowUD3YnDGsaAVvXKDBSgg3eRz3YKd7jCJD-yC6cvUUaTLaa0U7KenB-4bRXTMBDEhyrPxjYNc_2i_OPn86DKWN_yH-AIucTIMQydmE-clo6rbQsJmY7TCBnwHyy_gM |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7BIhUuPFpaFkoxoiekrBI79ibHqg9tH1sQaqUekCLbsatVIUH74MCJn9Df2F_SGSeNKEhI7SVylEmceDyehyffAGwKraQwWRoJm_goFT6O8tL7yJWZyLzSaRbikONjNTpND87kWZubQ__CNPgQXcCNJCOs1yTgFJD-U8rriR0klNXxEB6hvAuq3LDzpUOP4rEMBXfiLFf4FnzYopOGRJ7u3tv66B8j87bNGpTO3rOmsuosYBVSrsnFYDE3A_vrLyTHe3_Pc3jamqNsq5k_L-CBq5ZhadxuuK_A189TalNJHobmLftWV-dXvy9pPWezBS4zOFFZqDPO5qT1AgosnVGYjghrPFCbfZ9QTIUh_U_HpqgEJ9OXcLq3e7I9itqCDJEV6JdEMjXaW2Fyy0v0bKUntHhtlNVOeR3nmde25FYrHmvnuE_tUDjPM1nm6ApzLVahV9WVewXMIKGTcmiswqcmxqDrlygk9g6HwPI-fLhhS_Gjwd0oOn8FB6oIA9WH9RuOFa3szQq0WQnkJo_jPrzvLqPU0FaIrly9QJqMtlvRVEr6sNZwuusm4AFJjg__GPj1n_6Lg0_726H1-i7E7-Dx6GR8VBztHx--gSecLIUQ2FmH3ny6cG_RzpmbjTCbrwFU0vwk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB5RKqFeoAVKl9LWiJ4qZZXYsTeReqloV0D5U1UkDq0i27GrFZCgZZcDpz5Cn5EnYcbJRqVIldpL5CgT27E9nm_GzmeAt0IrKUyWRsImPkqFj6O89D5yZSYyr3SahTjkwaHaOUn3TuXpHLyf_QvT8EN0ATfSjDBfk4Jflv53Ja9Htp_Qpo5H8DhVCH0JEn3pyKN4LMN5O3GWK6wEH7TkpGEfT_fufXP0AGPeh6zB5gyX4Pusts1Wk7P-dGL69uYPIsf__ZynsNiCUfahGT3PYM5Vy7Bw0C63r8C34zGl6UAehuCWndfVj9ufv2g2Z1dTnGRwmLJwyjibkM0LHLB0R0E6EqzxQml2MaKICkP5a8fGaAJH41U4GX76ur0TtccxRFagVxLJ1GhvhcktL9GvlZ644rVRVjvldZxnXtuSW614rJ3jPrUD4TzPZJmjI8y1eA7zVV25F8AMCjopB8YqzDUxBh2_RKGwd9gElvdga9YrxWXDulF03go2VBEaqgcbsw4rWs27KhCxEsVNHsc92Oweo87QQoiuXD1FmYwWWxEoJT1Yazq6KyawAUmOmb8L3fWX8ou9o93tkFr_F-E3sHD8cVjs7x5-fglPOMGEENXZgPnJeOpeIciZmNdhLN8BdZr60w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+for+long-term+survival+after+transcatheter+edge-to-edge+mitral+valve+repair&rft.jtitle=Journal+of+interventional+cardiology&rft.au=Orban%2C+Mathias&rft.au=Orban%2C+Martin&rft.au=Lesevic%2C+Hasema&rft.au=Braun%2C+Daniel&rft.date=2017-06-01&rft.eissn=1540-8183&rft.volume=30&rft.issue=3&rft.spage=226&rft_id=info:doi/10.1111%2Fjoic.12376&rft_id=info%3Apmid%2F28370526&rft.externalDocID=28370526 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0896-4327&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0896-4327&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0896-4327&client=summon |